dm+d
21938911000001104
Articles
Insulin preparations: RMOC recommendations of safety considerations for formulary decision making
22 June 2018At its meeting on 18th April 2018 the Regional Medicines Optimisation Committee (RMOC) (Midlands and East) reviewed issues pertaining to safety considerations when adopting any…
New Medicines
TresibaType 1 diabetes mellitus in pregnant women
Information
Tresiba
Licence extension / variation
Novo Nordisk
Novo Nordisk
Development and Regulatory status
Phase III Clinical Trials
Phase III Clinical Trials
None
Category
Neutral soluble long acting insulin given 3 times a week
Approximately 2,625 people with pre-existing type 1 diabetes give birth in England and Wales each year [1].
Type 1 diabetes mellitus in pregnant women
Subcutaneous injection